The Patent Finder

Terms ending in 2033

Cellectis

Every in-force patent on Cellectis's record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,342,829Multi-Chain Chimeric Antigen Receptor and Uses Thereof
In force
 · Medium confidence
CellectisIn forceMedium confidence
US 10,517,896Use of Pre T Alpha or Functional Variant Thereof for Expanding TCR Alpha Deficient T Cells
In force
 · Low confidence
CellectisIn forceLow confidence
US 10,874,693CD19 Specific Chimeric Antigen Receptor and Uses Thereof
In force
 · Medium confidence
CellectisIn forceMedium confidence
US 11,007,224CD19 Specific Chimeric Antigen Receptor and Uses Thereof
In force
 · Low confidence
CellectisIn forceLow confidence
US 11,077,144CD19 Specific Chimeric Antigen Receptor and Uses Thereof
In force
 · High confidence
CellectisIn forceHigh confidence
US 11,274,316Use of Pre T Alpha or Functional Variant Thereof for Expanding TCR Alpha Deficient T Cells
In force
 · Low confidence
CellectisIn forceLow confidence
US 11,304,975Methods for Engineering Allogeneic and Highly Active T Cell for Immunotheraphy
In force
 · Low confidence
CellectisIn forceLow confidence
US 11,311,575Methods for Engineering Highly Active T Cell for Immunotheraphy
In force
 · Low confidence
CellectisIn forceLow confidence
US 11,414,674Use of Pre T Alpha or Functional Variant Thereof for Expanding TCR Alpha Deficient T Cells
In force
 · Low confidence
CellectisIn forceLow confidence
US 11,891,614Methods for Engineering Allogeneic and Immunosuppressive Resistant T Cell for Immunotherapy
In force
 · Medium confidence
CellectisIn forceMedium confidence
9 more term ends in 2033 · Pro
10 of 19 patents shown. Soonest term end first, then patent number.
Pro members see all 19.
Upgrade to Pro
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited